http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2553427-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e1f91931ac73496dbf072e0a2d8b7a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1acf8d8bea12221ede251c1fa3a65877 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c518907468f5181e4607be684b2b695c |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7946acfeb6ec43a130379f37787c6f77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48c60d4466613b4f2c91aa2ca8fe93a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2c93e9a218cbb87d861e2db2e55d024 |
| publicationDate | 2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2553427-C1 |
| titleOfInvention | Diagnostic technique for infected pancreonecrosis with establishing indications for surgical intervention |
| abstract | FIELD: medicine. n SUBSTANCE: invention describes a diagnostic technique for infected pancreonecrosis with establishing the indications for a surgical intervention by examining a patient, wherein acetic, propionic, butyric and isovaleric acids are measured in the blood by gas chromatography, and if the acetic acid concentration is more than 0.11 mmole/l enables stating infected pancreonecrosis, and if the concentration of any of three acids: propionic more than 0.095 mmole/l, butyric more than 0.0035 mmole/l, isovaleric acid more than 0.0003 mmole/l enables stating infected pancreonecrosis with active development of an anaerobic infection requiring one of versions of the surgical intervention. n EFFECT: invention enables providing the objective and accurate diagnosing of pancreonecrosis transformation into the stage of infection by using the qualitative parameters with no undesired side effects. n 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2701493-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2732726-C1 |
| priorityDate | 2013-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.